glp 1 drugs in development GLP-1 Drug Market: the rapid growth of the diabetes and obesity market What is the pipeline for
Description
Cost was not considered in the recommendations
These drugs are proven to be safe and effective for their intended uses
We also need to look at people who may not need weight reduction but are at high risk for cardiometabolic, renal hepatic and central nervous system disease
Pereira says that medication shortages impacted her patients, who had to switch to less effective drugs, which is especially concerning for patients with diabetes who need the medications to keep their blood glucose in a safe range
